Concepedia

Peter van Amsterdam

PV

Statistics

Publications

10

Citations

521

H-Index

10

Active since

1988

Affiliations

Abbott (Netherlands)(Current)

Janssen (Belgium)

Bayer (Germany)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United States)

Peter van Amsterdam is an author at Abbott (Netherlands) specializing in analytical chemistry, bioanalytical method validation, and pharmacy.

Publications per year

1988–2022

10

Publications

10

2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance

Natasha Savoie, Fabio Garofolo, Peter van Amsterdam et al. · Bioanalysis · 2010 · 122 citations

, , +15

2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections

Fabio Garofolo, Mario L. Rocci, Isabelle Dumont et al. · Bioanalysis · 2011 · 93 citations

, , +15

Incurred Sample Reproducibility: Views and Recommendations by the European Bioanalysis Forum

Philip Timmerman, Silke Luedtke, Peter van Amsterdam et al. · Bioanalysis · 2009 · 90 citations

, , +15

The European Bioanalysis Forum Community’s Evaluation, Interpretation and Implementation of The European Medicines Agency Guideline on Bioanalytical Method Validation

Peter van Amsterdam, Arjen Companjen, Margarete Brudny-Kloeppel et al. · Bioanalysis · 2013 · 88 citations

, , +16

Conformational determinants of high affinity delta receptor binding of opioid peptides.

C Keys, Philip W. Payne, Peter van Amsterdam et al. · Molecular Pharmacology · 1988 · 31 citations

, , +17

1–5 of 10